Marizyme Inc.
Biotechnology ResearchFlorida, United States11-50 Employees
Marizyme Inc. is a Jupiter, Florida-based biotechnology company focused on advancing cardiac care through medical technologies. The company develops products intended to reduce ischemia-reperfusion injury associated with tissue grafting, organ transplantation, and other surgical indications. Operating on a global scale, it positions itself within the biotechnology and medical technology sectors as a developer of therapies or devices that mitigate surgical injury. Its primary customers are healthcare providers, surgeons, and hospitals involved in tissue grafting and organ transplant procedures. In December 2021, Marizyme completed the acquisition of Health Logic Interactive, signaling an expansion of its strategic footprint.